BRIEF-Akebia Therapeutics Says Term Of Supply Agreement Extended For An Additional Five Years And Expires On April 2 2029

Reuters04-16

April 16 (Reuters) - Akebia Therapeutics Inc :

* AKEBIA THERAPEUTICS INC - TERM OF SUPPLY AGREEMENT IS EXTENDED FOR AN ADDITIONAL FIVE YEARS AND EXPIRES ON APRIL 2, 2029

* AKEBIA THERAPEUTICS INC - AMENDMENT AMENDS THE VOLUME-BASED PRICING STRUCTURE UNDER THE SUPPLY AGREEMENT

* AKEBIA THERAPEUTICS INC: ON APRIL 15, COMPANY AND STA ENTERED INTO AMENDMENT #2 TO SUPPLY AGREEMENT

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2427135829?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-16 20:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2427135829","market":"us","top_or_hot":-1,"title":"BRIEF-Akebia Therapeutics Says Term Of Supply Agreement Extended For An Additional Five Years And Expires On April 2 2029","media":"Reuters","content":"<html><body><p>April 16 (Reuters) - Akebia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * AKEBIA THERAPEUTICS INC - TERM OF SUPPLY AGREEMENT IS EXTENDED FOR AN ADDITIONAL FIVE YEARS AND EXPIRES ON APRIL 2, 2029</p><p>   * AKEBIA THERAPEUTICS INC - AMENDMENT AMENDS THE VOLUME-BASED PRICING STRUCTURE UNDER THE SUPPLY AGREEMENT</p><p>   * AKEBIA THERAPEUTICS INC: ON APRIL 15, COMPANY AND STA ENTERED INTO AMENDMENT #2 TO SUPPLY AGREEMENT</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Akebia Therapeutics Says Term Of Supply Agreement Extended For An Additional Five Years And Expires On April 2 2029</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Akebia Therapeutics Says Term Of Supply Agreement Extended For An Additional Five Years And Expires On April 2 2029\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-16 20:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>April 16 (Reuters) - Akebia Therapeutics Inc   :   * AKEBIA THERAPEUTICS INC - TERM OF SUPPLY AGREEMENT IS EXTENDED FOR AN ADDITIONAL FIVE YEARS AND EXPIRES ON APRIL 2, 2029   * AKEBIA THERAPEUTICS ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2427135829","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2427135829","pubTimestamp":1713270786,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"April 16  - Akebia Therapeutics Inc   :   * AKEBIA THERAPEUTICS INC - TERM OF SUPPLY AGREEMENT IS EXTENDED FOR AN ADDITIONAL FIVE YEARS AND EXPIRES ON APRIL 2, 2029   * AKEBIA THERAPEUTICS INC - AMENDMENT AMENDS THE VOLUME-BASED PRICING STRUCTURE UNDER THE SUPPLY AGREEMENT   * AKEBIA THERAPEUTICS INC: ON APRIL 15, COMPANY AND STA ENTERED INTO AMENDMENT #2 TO SUPPLY AGREEMENTSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","AKBA":"Akebia Therapeutics, Inc."},"translate_title":"简介-Akebia Therapeutics表示，供应协议的期限延长了五年，将于2029年4月2日到期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKBA":1},"content_text":"April 16 (Reuters) - Akebia Therapeutics Inc   :   * AKEBIA THERAPEUTICS INC - TERM OF SUPPLY AGREEMENT IS EXTENDED FOR AN ADDITIONAL FIVE YEARS AND EXPIRES ON APRIL 2, 2029   * AKEBIA THERAPEUTICS INC - AMENDMENT AMENDS THE VOLUME-BASED PRICING STRUCTURE UNDER THE SUPPLY AGREEMENT   * AKEBIA THERAPEUTICS INC: ON APRIL 15, COMPANY AND STA ENTERED INTO AMENDMENT #2 TO SUPPLY AGREEMENTSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.0","shortVersion":"4.24.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2427135829"}